In contrast, an increase in glycosylated Lamp1 has been previously characterized in Lrrk2 KO mice and in the postmortem brains of sporadic PD patients [30, 43] and is shown here in G2019S KI mice treated with MLi-2 and LRRK2 KO mice. This evidence concerns the gene LRRK2 and Parkinson disease.